RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 86 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,000 | -83.3% | 336 | -73.9% | 0.00% | – |
| Q4 2021 | $12,000 | -47.8% | 1,286 | 0.0% | 0.00% | – |
| Q3 2021 | $23,000 | -28.1% | 1,286 | -3.3% | 0.00% | – |
| Q2 2021 | $32,000 | -5.9% | 1,330 | +3.4% | 0.00% | – |
| Q1 2021 | $34,000 | +240.0% | 1,286 | 0.0% | 0.00% | – |
| Q4 2020 | $10,000 | +900.0% | 1,286 | +533.5% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 203 | -22.5% | 0.00% | – |
| Q1 2020 | $1,000 | – | 262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |